Ticker
JSPRCompany Name
JASPER THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Market Capitalization | Net Cash Flow - Issuance (Purchase) of Equity Shares | Net Cash Flow - Issuance (Repayment) of Debt Securities | Net Cash Flow - Dividends & Other Cash Distributions | Shareholder Yield |
---|---|---|---|---|---|
6/30/2025 | $ 48.27M | $ 6.52M | $ 0 | $ 0 | -13.5% |
3/31/2025 | $ 71.2M | $ 535K | $ 0 | $ 0 | -0.75% |
12/31/2024 | $ 89.08M | $ 47.88M | $ 0 | $ 0 | -53.75% |
9/30/2024 | $ 340.38M | $ 47.57M | $ 0 | $ 0 | -13.97% |
6/30/2024 | $ 284.73M | $ 47.59M | $ 0 | $ 0 | -16.72% |
3/31/2024 | $ 315.59M | $ 47.77M | $ 0 | $ 0 | -15.14% |
12/31/2023 | $ 374.49M | $ 101.93M | $ 0 | $ 0 | -27.22% |
9/30/2023 | $ 82.23M | $ 101.93M | $ 0 | $ 0 | -123.96% |
6/30/2023 | $ 154.01M | $ 101.9M | $ 0 | $ 0 | -66.16% |
3/31/2023 | $ 173.21M | $ 101.55M | $ 0 | $ 0 | -58.63% |
(-1 * CF - Equity -1 * CF - Dividends -1 * CF - Debt) / Market Cap
(=) Shareholder Yield
Shareholder Yield for JASPER THERAPEUTICS INC is calculated as follows: (-1 * CF - Equity [ $ 0 ] -1 * CF - Dividends [ $ 0 ] -1 * CF - Debt [ $ 0 ]) / Market Cap [ $ 123.38M ]
(=) Shareholder Yield [ 0% ]
Minimum
Sep 30, 2023
Maximum
Dec 31, 2020
Average
Median
filtered constituents | 3.48K |
---|---|
min | -33.43% |
max | 34.45% |
average | 0.58% |
median | 1.07% |
std | 11.13% |